Drug Information
| Drug General Information | Top | |||
|---|---|---|---|---|
| Drug ID |
D06HMY
|
|||
| Drug Name |
Biphenyl carboxamidopropanoic acid derivative 2
|
|||
| Synonyms |
PMID25828189-Compound-7
Click to Show/Hide
|
|||
| Drug Type |
Small molecular drug
|
|||
| Company |
JANSSEN PHARMACEUTICA NV CHAKRAVARTY, Devraj GRECO, Michael, N. SHOOK, Brian XU, Guozhang ZHANG, Rui
|
|||
| Structure |
 |
Download2D MOL |
||
| Formula |
C32H25ClF6N2O3
|
|||
| Canonical SMILES |
CC1=C(C=CC(=C1)C(F)(F)F)C2=C(C=C(C=C2)NCC3=C(C=C(C=C3)C(F)(F)F)C4=CC=C(C=C4)C(=O)NCCC(=O)O)Cl
|
|||
| InChI |
1S/C32H25ClF6N2O3/c1-18-14-22(31(34,35)36)8-10-25(18)26-11-9-24(16-28(26)33)41-17-21-6-7-23(32(37,38)39)15-27(21)19-2-4-20(5-3-19)30(44)40-13-12-29(42)43/h2-11,14-16,41H,12-13,17H2,1H3,(H,40,44)(H,42,43)
|
|||
| InChIKey |
XNDCNDSKAXXGMD-UHFFFAOYSA-N
|
|||
| PubChem Compound ID | ||||
| Target and Pathway | Top | |||
|---|---|---|---|---|
| Target(s) | Glucagon receptor (GCGR) | Target Info | Antagonist | [1] |
| Target's Patent Info | Glucagon receptor (GCGR) | Target's Patent Info | [1] | |
| KEGG Pathway | Neuroactive ligand-receptor interaction | |||
| Glucagon signaling pathway | ||||
| Reactome | Glucagon signaling in metabolic regulation | |||
| G alpha (q) signalling events | ||||
| G alpha (s) signalling events | ||||
| Glucagon-type ligand receptors | ||||
| WikiPathways | GPCRs, Class B Secretin-like | |||
| Gastrin-CREB signalling pathway via PKC and MAPK | ||||
| Integration of energy metabolism | ||||
| GPCR ligand binding | ||||
| GPCR downstream signaling | ||||
| References | Top | |||
|---|---|---|---|---|
| REF 1 | Small molecule glucagon receptor antagonists: a patent review (2011 - 2014).Expert Opin Ther Pat. 2015 Jul;25(7):819-30. | |||
If You Find Any Error in Data or Bug in Web Service, Please Kindly Report It to Dr. Zhou and Dr. Zhang.